news

Xaluprine® Regional Distribution

2013

iMed Group signed a regional distribution agreement with Nova Labs and RDT for only FDA/CE approved oral formulation of mercaptopurine, Xaluprine®. Xaluprine is used as maintenance therapy for acute lymphoblastic leukemia.